216 related articles for article (PubMed ID: 37585250)
21. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.
Wong IC; Asherson P; Bilbow A; Clifford S; Coghill D; DeSoysa R; Hollis C; McCarthy S; Murray M; Planner C; Potts L; Sayal K; Taylor E
Health Technol Assess; 2009 Oct; 13(50):iii-iv, ix-xi, 1-120. PubMed ID: 19883527
[TBL] [Abstract][Full Text] [Related]
22. Predicting Methylphenidate Response in ADHD Using Machine Learning Approaches.
Kim JW; Sharma V; Ryan ND
Int J Neuropsychopharmacol; 2015 May; 18(11):pyv052. PubMed ID: 25964505
[TBL] [Abstract][Full Text] [Related]
23. "Real-world" effectiveness of methylphenidate in improving the academic achievement of Attention-Deficit Hyperactivity Disorder diagnosed students-A systematic review.
de Faria JCM; Duarte LJR; Ferreira LA; da Silveira VT; Menezes de Pádua C; Perini E
J Clin Pharm Ther; 2022 Jan; 47(1):6-23. PubMed ID: 34254328
[TBL] [Abstract][Full Text] [Related]
24. Changes in Sleep Problems Across Attention-Deficit/Hyperactivity Disorder Treatment: Findings from the Multimodal Treatment of Attention-Deficit/Hyperactivity Disorder Study.
Ricketts EJ; Sturm A; McMakin DL; McGuire JF; Tan PZ; Smalberg FB; McCracken JT; Colwell CS; Piacentini J
J Child Adolesc Psychopharmacol; 2018 Dec; 28(10):690-698. PubMed ID: 30388029
[No Abstract] [Full Text] [Related]
25. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.
Kollins SH
J Clin Psychiatry; 2003; 64 Suppl 11():14-8. PubMed ID: 14529325
[TBL] [Abstract][Full Text] [Related]
26. The impact of methylphenidate on seizure frequency and severity in children with attention-deficit-hyperactivity disorder and difficult-to-treat epilepsies.
Santos K; Palmini A; Radziuk AL; Rotert R; Bastos F; Booij L; Fernandes BS
Dev Med Child Neurol; 2013 Jul; 55(7):654-60. PubMed ID: 23480530
[TBL] [Abstract][Full Text] [Related]
27. The potential for misuse and abuse of medications in ADHD: a review.
Clemow DB; Walker DJ
Postgrad Med; 2014 Sep; 126(5):64-81. PubMed ID: 25295651
[TBL] [Abstract][Full Text] [Related]
28. Academic, behavioral, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorder.
Wigal SB; Wigal T; Schuck S; Brams M; Williamson D; Armstrong RB; Starr HL
J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):121-31. PubMed ID: 21488750
[TBL] [Abstract][Full Text] [Related]
29. Safety of therapeutic methylphenidate in adults: a systematic review of the evidence.
Godfrey J
J Psychopharmacol; 2009 Mar; 23(2):194-205. PubMed ID: 18515459
[TBL] [Abstract][Full Text] [Related]
30. Crocus sativus L. Versus Methylphenidate in Treatment of Children with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Pilot Study.
Baziar S; Aqamolaei A; Khadem E; Mortazavi SH; Naderi S; Sahebolzamani E; Mortezaei A; Jalilevand S; Mohammadi MR; Shahmirzadi M; Akhondzadeh S
J Child Adolesc Psychopharmacol; 2019 Apr; 29(3):205-212. PubMed ID: 30741567
[TBL] [Abstract][Full Text] [Related]
31. Abuse liability of medications used to treat attention-deficit/hyperactivity disorder (ADHD).
Kollins SH
Am J Addict; 2007; 16 Suppl 1():35-42; quiz 43-4. PubMed ID: 17453605
[TBL] [Abstract][Full Text] [Related]
32. Early exposure to stimulant medications and substance-related problems: The role of medical and nonmedical contexts.
McCabe SE; Veliz P; Boyd CJ
Drug Alcohol Depend; 2016 Jun; 163():55-63. PubMed ID: 27129621
[TBL] [Abstract][Full Text] [Related]
33. Treatment effect of methylphenidate on intrinsic functional brain network in medication-naïve ADHD children: A multivariate analysis.
Yoo JH; Kim D; Choi J; Jeong B
Brain Imaging Behav; 2018 Apr; 12(2):518-531. PubMed ID: 28417219
[TBL] [Abstract][Full Text] [Related]
34. Methylphenidate and dextroamphetamine abuse in substance-abusing adolescents.
Williams RJ; Goodale LA; Shay-Fiddler MA; Gloster SP; Chang SY
Am J Addict; 2004; 13(4):381-9. PubMed ID: 15370936
[TBL] [Abstract][Full Text] [Related]
35. Adverse Drug Reactions Related to Mood and Emotion in Pediatric Patients Treated for Attention Deficit/Hyperactivity Disorder: A Comparative Analysis of the US Food and Drug Administration Adverse Event Reporting System Database.
Pozzi M; Carnovale C; Mazhar F; Peeters GGAM; Gentili M; Nobile M; Radice S; Clementi E
J Clin Psychopharmacol; 2019; 39(4):386-392. PubMed ID: 31205193
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of osmotic-release oral system (OROS) methylphenidate for mothers with attention-deficit/hyperactivity disorder (ADHD): preliminary report of effects on ADHD symptoms and parenting.
Chronis-Tuscano A; Seymour KE; Stein MA; Jones HA; Jiles CD; Rooney ME; Conlon CJ; Efron LA; Wagner SA; Pian J; Robb AS
J Clin Psychiatry; 2008 Dec; 69(12):1938-47. PubMed ID: 19192455
[TBL] [Abstract][Full Text] [Related]
37. Safety of Methylphenidate and Atomoxetine in Children with Attention-Deficit/Hyperactivity Disorder (ADHD): Data from the Italian National ADHD Registry.
Cortese S; Panei P; Arcieri R; Germinario EA; Capuano A; Margari L; Chiarotti F; Curatolo P
CNS Drugs; 2015; 29(10):865-77. PubMed ID: 26293742
[TBL] [Abstract][Full Text] [Related]
38. Treatment of attention-deficit/hyperactivity disorder.
Jadad AR; Boyle M; Cunningham C; Kim M; Schachar R
Evid Rep Technol Assess (Summ); 1999 Nov; (11):i-viii, 1-341. PubMed ID: 10790990
[TBL] [Abstract][Full Text] [Related]
39. Natural Health Product-Drug Interaction Causality Assessment in Pediatric Adverse Event Reports Associated with Attention-Deficit/Hyperactivity Disorder Medication.
Mazhar H; Foster BC; Necyk C; Gardiner PM; Harris CS; Robaey P
J Child Adolesc Psychopharmacol; 2020 Feb; 30(1):38-47. PubMed ID: 31670573
[No Abstract] [Full Text] [Related]
40. A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents.
Soutullo C; Banaschewski T; Lecendreux M; Johnson M; Zuddas A; Anderson C; Civil R; Higgins N; Bloomfield R; Squires LA; Coghill DR
CNS Drugs; 2013 Sep; 27(9):743-51. PubMed ID: 23801529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
